This trial is for kids with a rare cancer called Langerhans Cell Histiocytosis.
6 Primary · 22 Secondary · Reporting Duration: 3 Years
Experimental Treatment
1400 Total Participants · 6 Treatment Groups
Primary Treatment: Vinblastine · No Placebo Group · Phase 2 & 3
Age < 65 · All Participants · 10 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you: